Aperio Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$33.4M Sell
69,153
-10,183
-13% -$4.92M 0.1% 199
2020
Q3
$44.4M Buy
79,336
+7,136
+10% +$3.99M 0.15% 131
2020
Q2
$45M Buy
72,200
+17,805
+33% +$11.1M 0.17% 116
2020
Q1
$26.6M Buy
54,395
+23,864
+78% +$11.7M 0.12% 179
2019
Q4
$11.5M Buy
30,531
+7,355
+32% +$2.76M 0.04% 460
2019
Q3
$6.43M Sell
23,176
-3,623
-14% -$1.01M 0.03% 623
2019
Q2
$8.39M Sell
26,799
-13,571
-34% -$4.25M 0.03% 530
2019
Q1
$16.6M Buy
40,370
+2,940
+8% +$1.21M 0.07% 308
2018
Q4
$14M Buy
37,430
+5,038
+16% +$1.88M 0.07% 307
2018
Q3
$13.1M Buy
32,392
+4,060
+14% +$1.64M 0.06% 360
2018
Q2
$9.78M Buy
28,332
+2,045
+8% +$706K 0.05% 444
2018
Q1
$9.05M Buy
26,287
+1,330
+5% +$458K 0.05% 451
2017
Q4
$9.38M Sell
24,957
-1,301
-5% -$489K 0.05% 435
2017
Q3
$11.7M Sell
26,258
-806
-3% -$360K 0.07% 348
2017
Q2
$13.3M Buy
27,064
+7,649
+39% +$3.76M 0.08% 296
2017
Q1
$7.52M Sell
19,415
-2,375
-11% -$920K 0.05% 418
2016
Q4
$8M Sell
21,790
-3,389
-13% -$1.24M 0.06% 367
2016
Q3
$10.1M Buy
25,179
+1,566
+7% +$630K 0.07% 317
2016
Q2
$8.25M Buy
23,613
+2,414
+11% +$843K 0.06% 341
2016
Q1
$7.64M Sell
21,199
-2,270
-10% -$818K 0.07% 343
2015
Q4
$12.7M Buy
23,469
+3,217
+16% +$1.75M 0.12% 198
2015
Q3
$9.42M Buy
20,252
+2,710
+15% +$1.26M 0.1% 251
2015
Q2
$8.95M Buy
17,542
+2,549
+17% +$1.3M 0.09% 263
2015
Q1
$6.77M Buy
14,993
+2,241
+18% +$1.01M 0.08% 323
2014
Q4
$5.23M Buy
12,752
+1,078
+9% +$442K 0.06% 368
2014
Q3
$4.21M Buy
11,674
+1,546
+15% +$557K 0.06% 395
2014
Q2
$2.86M Buy
10,128
+1,202
+13% +$340K 0.04% 492
2014
Q1
$2.68M Buy
+8,926
New +$2.68M 0.04% 603
2013
Q4
Sell
-6,234
Closed -$1.95M 670
2013
Q3
$1.95M Buy
6,234
+115
+2% +$36K 0.04% 597
2013
Q2
$1.38M Buy
+6,119
New +$1.38M 0.03% 634